Exagen Inc.

Exagen Inc.verified

XGN

Price:

$7.49

Market Cap:

$169.75M

Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by...[Read more]

Industry

Medical - Diagnostics & Research

IPO Date

2019-09-19

Stock Exchange

NASDAQ

Ticker

XGN

The Enterprise Value as of December 2025 (TTM) for Exagen Inc. (XGN) is 142.61M

According to Exagen Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 142.61M. This represents a change of 81.61% compared to the average of 78.52M of the last 4 quarters.

Exagen Inc. (XGN) Historical Enterprise Value (quarterly & annually)

How has XGN Enterprise Value performed in the past?

The mean historical Enterprise Value of Exagen Inc. over the last ten years is 69.77M. The current 142.61M Enterprise Value has changed 20.34% with respect to the historical average. Over the past ten years (40 quarters), XGN's Enterprise Value was at its highest in in the December 2019 quarter at 272.81M. The Enterprise Value was at its lowest in in the September 2019 quarter at -28532702.39.

Quarterly (TTM)
Annual

Average

69.77M

Median

23.49M

Minimum

8.77M

Maximum

272.82M

Exagen Inc. (XGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Exagen Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.05%

Maximum Annual Enterprise Value = 272.82M

Minimum Annual Increase = -87.19%

Minimum Annual Enterprise Value = 8.77M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202475.96M238.95%
202322.41M52.91%
202214.66M-87.19%
2021114.38M-16.22%
2020136.53M-49.96%
2019272.82M2.05%
201812.70M44.94%
20178.77M-64.31%
201524.56M64.18%
201414.96M589.59%

Exagen Inc. (XGN) Average Enterprise Value

How has XGN Enterprise Value performed in the past?

The current Enterprise Value of Exagen Inc. (XGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

37.68M

5-year avg

72.79M

10-year avg

69.77M

Exagen Inc. (XGN) Enterprise Value vs. Peers

How is XGN’s Enterprise Value compared to its peers?

Exagen Inc.’s Enterprise Value is less than NeoGenomics, Inc. (557.09M), less than MDxHealth S.A. (236.06M), less than Aclaris Therapeutics, Inc. (303.08M), less than Stereotaxis, Inc. (221.00M), less than Sanara MedTech Inc. (227.24M), less than Sight Sciences, Inc. (348.58M), less than Alpha Teknova, Inc. (271.24M), less than BioAge Labs, Inc. (168.04M), less than Lifecore Biomedical, Inc. (413.25M), less than Vanda Pharmaceuticals Inc. (243.49M),

CompanyEnterprise ValueMarket cap
557.09M$310.90M
236.06M$180.17M
303.08M$326.12M
221.00M$225.93M
227.24M$194.79M
348.58M$440.95M
271.24M$258.55M
168.04M$376.48M
413.25M$290.70M
243.49M$307.28M

Build a custom stock screener for Exagen Inc. (XGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exagen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Exagen Inc. (XGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Exagen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Exagen Inc.'s Enterprise Value?

What is the highest Enterprise Value for Exagen Inc. (XGN)?

What is the 3-year average Enterprise Value for Exagen Inc. (XGN)?

What is the 5-year average Enterprise Value for Exagen Inc. (XGN)?

How does the current Enterprise Value for Exagen Inc. (XGN) compare to its historical average?